Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01759745Withdrawn

Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm

Role: lead

NCT02179450Completed

Cognitive Function and Emotional Possessing in Bilateral Facial Palsy

Role: lead

NCT01523210Completed

DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle

Role: lead

All 3 trials loaded